Notfälle
Blutspende
Karriere
Presse
Forschung
Lehre
Patienten
Zuweiser

 

 

Link zu Esther

Since 07/01/2013

In Ethiopia, two thirds of all cancer patients are women, and out of these, almost half are affected by cervical cancer. The latency for cervical cancer is between 10 – 20 years with about 4 years of symptomatic disease. Therefore, considering that an estimated 10.000 new cases occur yearly in Ethiopia, each living with the disease for 20 years, a total of 200.000 women are affected. This includes early stages without any symptoms and more advanced stages with bleeding, infections, severe pain, as well as anemia and eventually incontinence and renal failure.

Prevention of HPV infection as well as access to cervical cancer screening for early detection and access to treatment is an important pre-requisit for improved health of women. The partnership contributes to improvement in all three areas and provides evidence of the relevance to the Ministry of health through data gained by operational research.

 

PARTNERS INVOLVED

    NORTH
    Martin Luther University
    Medical Faculty Department of Gynaecology
    Halle, Germany

     SOUTH
Addis-Ababa-University
Radiotherapy Center and Department of Gynaecology and Department of Pathology and School of Public Health

Cervical cancer awareness and prevention strategies are presented as recommendations to the Federal Ministry of Health for policy development and access to services for cervical cancer patients in the catchment area of the university hospital of Addis Ababa is improved.

OUTPUTS

1. Evidence is generated for awareness and prevention strategies according to the risk factor profile of cervical cancer in the context of NCDs.

2. HPV prevalence in normal population and genotypes of cervical cancer patients are estimated and population based incidence rates are established in selected areas.

3. Histo-technicians and gynaecologists at AAU are better qualified to offer cervical cancer diagnosis and treatment.

4. Radiotherapists are upgraded and certified.

AREAS OF INTERVENTION

■ Capacity Strengthening

■ Operational Research

■ Prevention

OUTCOME INDICATORS

Outcome Indicator 1:

HPV prevalence and genotypes as well as cervical cancer incidence have been established and documented and strategies for awareness creation have been elaborated.

Outcome Indicator 2:

Number of women affected searching cervical cancer treatment is increased by 20% within the project period of 2 years.

HISTORY OF THE PARTNERSHIP 

The ESTHER partnership started in July 2013.